Intro
Preface
Contents
1: Epidemiology and Risk Factors of Invasive Fungal Infections
1.1 Introduction
1.2 Hematopoietic Stem Cell Transplantation (HSCT)
1.3 Acute Leukemia
1.4 Other Hematologic Diseases
1.5 Invasive Candidiasis
1.6 Other Invasive Yeast Infections
1.7 Invasive Aspergillosis
1.8 Mucormycosis
1.9 Fusariosis
1.10 Other Invasive Mold Infections
1.11 Pneumocystosis
1.12 Endemic Mycoses
1.13 Risk Stratification and Preventive Strategies
References
2: Antibacterial and Antiparasitic Prophylaxis
2.1 Introduction

2.2 Antibacterial Prophylaxis
2.2.1 Who Is at Risk?
2.2.2 Antibacterial Prevention Strategies in Neutropenic Patients: Past and Present
2.3 Concerns About Antibiotic Prophylaxis
2.3.1 Treatment Cost
2.3.2 Antibiotic Resistance
2.4 Antiparasitic Prophylaxis
2.4.1 Introduction
2.4.2 Recommendations for Prevention of Specific Infections
2.4.2.1 Enteric Pathogens
2.4.2.2 Infections Transmitted by Arthropod Bites
2.4.2.3 Infections Transmitted Through Skin and Mucous Membranes
References
3: Antifungal Prophylaxis
3.1 Introduction

3.2 General Measures for Prevention of Invasive Fungal Infections
3.3 Acute Myeloid Leukaemia and Myelodysplastic Syndromes
3.4 Allogeneic Haematopoietic Stem Cell Transplantation
3.5 Autologous Haematopoietic Stem Cell Transplantation
3.6 Novel Therapeutic Agents and Fungal Risk in Other Haematological Malignancies
3.7 Aplastic Anaemia
3.8 Secondary Prophylaxis
3.9 Primary Prophylaxis as Part of the Antifungal Management Continuum
References
4: Antiviral Prophylaxis
4.1 Herpes Viruses
4.1.1 Herpes Simplex Virus (HSV)

4.1.2 Varicella-Zoster Virus (VZV)
4.1.3 Cytomegalovirus (CMV)
4.2 Respiratory Viruses
4.3 Hepatotropic Viruses
4.4 Polyomaviruses
4.5 Other Viruses
References
5: Immune Response to Vaccines
5.1 Introduction
5.2 Vaccine Immune Response
5.2.1 Live Vaccines
5.2.2 Non-Live Vaccines
5.2.3 Vaccine Adjuvants
5.2.4 Stages of Immunization
5.2.4.1 The Extrafollicular Vaccine Immune Reaction
5.2.4.2 The Germinal Centre Vaccine Immune Reaction
5.3 Determining Factors of Vaccine Immune Response
5.3.1 Host Factors
5.3.1.1 Age

5.3.1.2 Genetic Factors
5.3.2 Nature of the Vaccine
5.3.3 Schedule of Vaccination
5.4 Specificity of Vaccine Immune Response
References
6: Vaccine-Preventable Diseases
6.1 Influenza
6.1.1 Hematological Malignancies and Influenza
6.1.2 Hematopoietic Stem Cell Transplantation (HSCT) and Influenza
6.1.2.1 Timing of the Vaccination
6.1.2.2 Vaccination of the Household
6.1.2.3 Vaccination of the Donor
6.2 Fungal Infections and Vaccination
6.3 Herpes Zoster
6.3.1 Hematological Malignancies and Herpes Zoster